Hikma Pharmaceuticals (HIKL)

1,539.00p
   
  • Change Today:
      3.00p
  • 52 Week High: 2,348.00
  • 52 Week Low: 1,505.00
  • Currency: UK Pounds
  • Shares Issued: 199.39m
  • Volume: 24,153
  • Market Cap: £3,068.54m

HIKL Overview

Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma’s operations are in the United States, the Middle East and North Africa Region and Europe.

Key Personnel

Executive Chairman: Said Darwazah
Executive Vice Chairman: Mazen Darwazah
Independent Non-Executive Director: Douglas Hurt
Independent Non-Executive Director: Laura Balan Balan
Independent Non-Executive Director: Mary (Nina) Henderson
Independent Non-Executive Director: Cynthia Schwalm
Independent Non-Executive Director: Deneen Vojta
Senior Independent Director: Victoria Hull
Non-Executive Dir: Ali Al-Husry

Contact Details

Address: 1 New Burlington Place, London,United Kingdom, W1S 2HR
Phone: +44 (0)20 7399 2760
Fax: +44 (0)20 7399 2761
Website: http://www.hikma.com

Listings

Overseas Listings: LSE:HIK
ISIN: GB00B0LCW083

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 5 minutes.

 

HIKL Market Data

Currency UK Pounds
Share Price 1,539.00p
Change Today 3.00p
% Change 0.20 %
52 Week High 2,348.00
52 Week Low 1,505.00
Volume 24,153
Shares Issued 199.39m
Market Cap £3,068.54m

What The Brokers Say

Strong Buy 7
Buy 3
Neutral 2
Sell 0
Strong Sell 0
Total 12
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 30-Dec-2025

Time Volume / Share Price
12:24 316 @ 1,539.00p
12:24 26 @ 1,539.00p
12:24 3 @ 1,539.00p
12:22 335 @ 1,540.00p
12:22 309 @ 1,540.00p

Top of Page